Is the price fair?
What ONC's price assumes
BeOne Medicines AG did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 77.9× revenue.
77.9
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 93.9
Price / book · as of 2026-Q1
- EV / sales
- 77.2
EV / sales
Details›
- Price / book2026-Q1
- 93.9
- EV / EBIT2026-Q1
- 646
- EV / sales2026-Q1
- 77.2
- Market capitalisation
- $28.0B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
Ranks #58 of 145 by Smart Score